**For the first time, researchers have developed a non-intrusive way to generate large quantities of stem cells using only a small amount of blood**

**The stem cells can repair cells damaged as a result of vascular diseases, which has the potential to prevent blindness and reverse the need for amputations**

A discovery by researchers at Queen’s University Belfast and King’s College London (KCL) could revolutionise treatment for vascular and diabetes related cardiovascular diseases.

The researchers have developed technology that can produce large quantities of stem cells in a short time, using only a small blood sample. They have also found that the stem cells produced can generate and replace damaged cells within blood vessels. This treatment could prevent a range of vascular-related complications including heart attacks, kidney disease, blindness and amputations in people with diabetes.

Principal Investigator, Dr Andriana Margariti from the Wellcome-Wolfson Institute for Experimental Medicine at Queen’s University Belfast, explains: “Being able to produce large quantities of stem cells from a few millilitres of blood in a short timeframe is truly ground-breaking. This could revolutionise how we treat a vast number of blood vessel diseases.”

“Previously, this cell transformation process would have involved a skin biopsy, or large volumes of blood, which simply isn’t viable for many patients as it is a risky process which can take a long recovery time.”

“This study focused on stem cells for vascular diseases but the same process can be used to produce stem cells for a number of organs, including the brain and kidneys, which has huge implications for the future of healthcare.”

The Queen’s and KCL researchers have also discovered that activating a particular gene known as Endothelial Specific Molecule 1 (ESM1) in the stem cells could enhance the production and function of newly generating endothelial cells, which play a key role in a number of vascular diseases. 

Endothelial cells line the blood vessels, acting as a protective barrier. As the top layer of cells in the blood vessels, it is these cells that become seriously damaged in cardiovascular disease, and this is often accelerated in patients with diabetes.

People with cardiovascular disease and diabetes are more likely to suffer from heart attacks, blindness and poor circulation because their endothelial cells are damaged.

Dr Margariti explains: “A major source of mortality among those with cardiovascular diseases, and especially patients with diabetes, is due to irreversible damage to their endothelial cells which can lead to blockage of blood flow to the heart, eyes, kidney and limbs.”

“One in every two people with diabetes will die from a heart attack. Current treatment for diabetes is often limited to drugs that regulate sugars and fats in the blood and hypertension but unless the endothelial cells are repaired, unfortunately, the illness will continue to progress.”

The preclinical study, published in Stem Cell Journals, showed that stem cells expressing the ESM1 gene have a remarkable regenerative potential and significantly increased the blood-flow when they were tested in damaged blood vessels.

In a concept known as cell therapy, damage can be repaired through the transplantation of healthy endothelial cells. Professor Alan Stitt, Dean of Innovation and Education at Queen’s University Belfast and co-author explained: “Through the technology developed, we can readily produce stem cells to transplant to damaged blood vessels. We have discovered that activating the particular gene ESM1 will improve the production and function of endothelial cells, reversing the damaged cells. This is life-changing as the results have shown that repairing these cells can stop the progressive illnesses, which will prevent blindness and amputations.”   

“Cell transplantation has huge potential though it is not suitable for all vascular diseases such as coronary disease. Now we know how to generate and improve the function of these cells, we will focus on screening drugs to see which treatments will further improve the function of these cells and ultimately improve the lives of millions of people afflicted with these illnesses.”

Head of British Heart Foundation Northern Ireland Fearghal McKinney said: “We are delighted to have funded Dr Margariti and to see how BHF funding can deliver ground breaking science that can make a difference to the lives of people living with heart and circulatory disease here.

“There’s no doubt that people vastly underestimate the danger of diabetes. The condition significantly increases the risk of heart attack and stroke, and research has shown that it can also contribute to the development of vascular dementia.

“A quarter of people living with coronary heart disease in Northern Ireland also have diabetes and  adults with diabetes are up to three times more likely to develop heart and circulatory conditions.

“The more we have learned about the circulatory system through research like Dr Margariti’s, the clearer it has become that managing risk factors such as diabetes can reduce your chances of suffering a heart attack or stroke. This is why our research looks beyond the heart, in order to find a more coordinated approach to managing these life threatening conditions.”